A Placebo-controlled, Randomized, Double Blind, Multiple Ascending Dose, Multiple Cohort, Multicentre Study to Assess Safety, Tolerability, Pharmacokinetics & Efficacy of PNB-001 (Test, Manufactured by PNB Vesper Life Science Pvt. Ltd., India)
Latest Information Update: 04 Mar 2020
At a glance
- Drugs PNB 001 (Primary)
- Indications Dysmenorrhoea; Inflammatory bowel diseases; Ulcerative colitis
- Focus Adverse reactions
- Sponsors PNB Vesper Life Science
Most Recent Events
- 30 Jan 2020 New trial record